| Literature DB >> 32370024 |
Jesús A Álvarez Martínez1, Julio V Figueroa Millán1, Massaro W Ueti2, Carmen Rojas-Martínez1.
Abstract
In this study, we report Babesia bigemina proliferation in culture medium free of components of animal origin supplemented with a lipid mixture. Babesia bigemina continuously proliferated in VP-SFM with a higher percent parasitized erythrocyte as compare to using other animal component-free culture media. Compared with Advanced DMEM/F12 (ADMEM/F12), VP-SFM had a similar percent parasitized erythrocyte (PPE). Supplementation of VP-SF with a lipid acid mixture improved B. bigemina proliferation in vitro culture, with a maximum PPE of 11.3%. Growth of B. bigemina in a perfusion bioreactor using VP-SFM medium supplemented with lipid mixture resulted in a PPE above 28%. In conclusion, we demonstrated that B. bigemina proliferated in an animal component-free medium supplemented with the fatty acid mixture. This innovation to B. bigemina in vitro culture method presented herein is an important source of biological material for live vaccine production and understanding the mechanisms and molecules involved in parasite attachment and invasion of bovine erythrocytes.Entities:
Keywords: Babesia bigemina; CD-lipids; animal component-free medium; in vitro culture
Year: 2020 PMID: 32370024 PMCID: PMC7281159 DOI: 10.3390/pathogens9050343
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Growth of B. bigemina in media free of animal products.
| Medium | Serum-Free | Animal-Free Components | Protein-Free |
|---|---|---|---|
| ADMEM/F12 | Yes | No | No |
| CD-CHO (Gibco®), | Yes | Yes | Yes |
| CD-CHO (Sigma-Aldrich) | Yes | Yes | Yes |
| CD-Hydrolyzed (Sigma-Aldrich) | Yes | Yes | Yes |
| VP-SFM (Gibco®) | Yes | Yes | No |
Lipid concentration used for in vitro B. bigemina proliferation.
| Treatment | Lipids Mixture Concentration (mg/mL) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Myristic | Palmitic | Palmitoleic | Stearic | Oleic | Linolenic | Stearic | Arachidonic | Cholesterol | |
| I | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.04 | 4.4 |
| II | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.02 | 2.2 |
| III | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | 1.1 |
| IV | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.025 | 0.005 | 0.55 |
| V | 0.0125 | 0.0125 | 0.0125 | 0.0125 | 0.0125 | 0.0125 | 0.0125 | 0.0025 | 0.275 |
Lipid concentration: half-dilution factor.
Figure 1Babesia bigemina growth curve using animal component-free media. The percent of parasitized erythrocyte (PPE) was adjusted to 1% when PPE reached 4%. If the PPE was ≤1 then a 1:2 subculture was carried out. Subcultures are not shown.
Figure 2Comparison of Babesia bigemina proliferation between VP-SFM and ADMEM/F12 control medium. The percentage of parasitized erythrocytes (PPE) was adjusted to 1% when reached 4%. If the PPE was ≤1 then a 1:2 subculture was carried out. Subcultures are not shown.
Effect of lipid concentration on in vitro B. bigemina proliferation.
| Treatment | Days of Culture | ||||||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | |
| I | 1.0% | 2.43% | 5.71% | 8.00% | 7.92% | 8.96% | 8.03% |
| II | 1.0% | 4.93% | 7.19% * | 9.85% * | 10.33% * | 10.43% * | 11.35% * |
| II | 1.0% | 4.77% | 5.03% | 7.91% | 8.70% | 8.60% | 9.04% |
| IV | 1.0% | 4.20% | 5.08% | 7.06% | 7.77% | 5.25% | 8.10% |
| V | 1.0% | 3.12% | 3.74% | 5.49% | 5.61% | 8.60% | 7.06% |
| VP-SFM | 1.0% | 1.77% | 4.40% | 4.99% | 6.07% | 7.42% | 7.43% |
Treatment lipid: one-half dilution factor as described in Table 2. Asterisks indicate significant difference between treatments.
Figure 3Comparison of growth curve of Babesia bigemina proliferation using VP-SFM + lipid with ADMEM/F12 control medium. The parasitemia was adjusted to 1% when the percentage of parasitized erythrocytes (PPE) reached 4. If the PPE was ≤1 then a 1:2 subculture was carried out. Subcultures are not shown.
Figure 4Babesia bigemina proliferation in a perfusion bioreactor. (A) Growth comparison of B. bigemina between VP-SFM + lipid mixture and ADMEM/F12 control medium. (B) Giemsa-stained blood smear showing B. bigemina parasitized erythrocytes.